Option Care Health Delivers Solid Q2 2026 and Lifts Full-Year EPS Outlook

summarizeSummary

Second-quarter revenue reached $1.44 billion, and the company lifted its full-year Adjusted EPS guidance to $1.85–$1.92, pointing to strengthening operational momentum after a soft first quarter.

check_boxKey Events · Earnings and Guidance · OPCH

• Q2 Revenue and Earnings Beat

  Net revenue came in at $1,442 million, a 1.9% year-over-year increase, while Adjusted EBITDA rose 3.0% to $117.5 million and Adjusted diluted EPS grew 9.8% to $0.45.

• Full-Year Guidance Raised

  The full-year outlook now calls for Adjusted diluted EPS of $1.85–$1.92, Adjusted EBITDA of $480–$495 million, and net revenue of $5.675–$5.775 billion.

• Q3 Sequential Growth Outlook

  For the third quarter, management projects low-to-mid single-digit sequential revenue growth and mid single-digit sequential Adjusted EBITDA growth relative to Q2.

• Share Repurchases Continue

  During Q2 2026, the company bought back $150 million of its shares, helping reduce the weighted average diluted share count to 153.5 million from 164.1 million a year ago.

auto_awesomeAnalysis · OPCH · Industrial Applications And Services

A steady second quarter saw revenue climb 1.9% to $1.44 billion while Adjusted EBITDA advanced 3% to $117.5 million. Bolstered by these results, management raised its full-year Adjusted diluted EPS target to $1.85–$1.92, up from prior implied levels, and outlined Q3 sequential growth targets. The $150 million deployed for share repurchases during the quarter highlights management's conviction and lends support to per-share metrics. Coming on the heels of a mixed Q1 that had weighed on the stock, the improved outlook offers a positive signal for the balance of 2026.